Cryo-Cell International, Inc. CCEL 深 滬
等待開盤 02-07 09:30:00 美东时间
3.38
+0.010
+0.30%
華盛通- 最 高3.525
- 今 開3.40
- 成交量 5.89万股
- 最 低 3.29
- 昨 收 3.37
- 總市值 2722.64万
- 52周最高 8.0405
- 市盈率 靜 68.98
- 換手率 0.00%
- 52周最低 3.10
- 委 比 87.83%
- 總股本 805.51万
- 歷史最高 12.61
- 量 比 3.64
- 振 幅 6.97%
- 歷史最低 2.04
- 每 手 1
- 風險率 1.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Maxim Group Downgrades Cryo-Cell International to Hold
Maxim Group analyst Allen Klee downgrades Cryo-Cell International (AMEX:CCEL) from Buy to Hold.
2025-10-20 21:20
Cryo-Cell Schedules 2025 Annual Stockholders Meeting
Cryo-Cell International ( ($CCEL) ) has provided an announcement. Cryo-Cell Int...
2025-09-11 05:33
Cryo-Cell International Q2 EPS $0.04 Beats $(0.05) Estimate, Sales $7.929M Miss $8.041M Estimate
Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.05) by 180 percent. This is a 50 percent decrease over earnings of $0.08 per share
2025-07-16 05:04
Cryo-Cell Faces License Termination by Duke University
Cryo-Cell International ( ($CCEL) ) has issued an update. Cryo-Cell Internation...
2025-05-23 05:36
美股大行评级 | 富国银行：维持艾伯维"超配"评级，目标价从210美元升至240美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1104327819967434752.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Syndax制药(SNDX)"超配"评级，目标价从35美元升至39美元</p> <p>• 摩根大通：维持AnaptysBio(ANAB)"超配"评级，目标价从36美元升至42美元</p> <p>• 摩根大通
2025-03-06 11:20
美股大行评级 | 美银证券：维持艾伯维"中性"评级，目标价从200美元升至223美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1103964892578983937.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Syndax制药(SNDX)"超配"评级，目标价从35美元升至39美元</p> <p>• 摩根大通：维持Apellis Pharmaceuticals(APLS)"超配"评级，目标价从50美元升至54美元</
2025-03-05 09:55
CRYO-CELL International declares $0.25 dividend
CRYO-CELL International (NYSE:CCEL) declares $0.25/share quarterly dividend. Forward yield 17.18% Payable Nov. 29; for shareholders of record Nov. 15; ex-div Nov. 15. See CCEL Dividend Scorecard, Yiel...
2024-10-30 20:59
CRYO-CELL International GAAP EPS of $0.08 beats by $0.04, revenue of $8M beats by $0.05M
CRYO-CELL International press release (NYSE:CCEL): Q2 GAAP EPS of $0.08 beats by $0.04. Revenue of $8M (+3.0% Y/Y) beats by $0.05M. More on CRYO-CELL International Earnings week ahead: PepsiCo, Delta ...
2024-07-16 04:36
Cryo-Cell International(CCEL.US)：2024年Q1财报实现营收785万美元，前值为782万美元，预期值为793万美元；每股收益为0.07美元，前值为0.09美元，预期值为-0.02美元。
Cryo-Cell International(CCEL.US)：2024年Q1财报实现营收785万美元，前值为782万美元，预期值为793万美元；每股收益为...
2024-04-16 06:51
Cryo-Cell International Announces Strategic Subsidiary Spin-Off Plans
Cryo-Cell International Inc (CCEL) has provided an announcement. Cryo-Cell Inte...
2024-03-26 20:44
